Volpara Health Technologies Limited
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a VPAHF research report →
Companywww.volparahealth.com
Volpara Health Technologies Limited provides breast imaging analytics software products in New Zealand. The company offers Volpara Analytics, a software that optimize breast cancer screening operations; Volpara Live, which provides instant patient-based image quality feedback; Volpara Lung, a patient management software that streamlines lung screening workflow; and Volpara Patient Hub, a customizable mammography reporting and patient communications software. It also offers Volpara Risk, an integration with Patient Hub that uses TC8 to calculate patients' risk of developing breast cancer; Volpara Risk Pathways, a program for identifying and managing high-risk breast cancer screening patients; Volpara Scorecard, which displays patient breast density and risk insights essential for improved clinical decision-making and early detection; and Volpara Science, an AI-based software that powers Volpara software products.
- CEO
- Teri Jo Thomas
- IPO
- 2018
- Employees
- 156
- HQ
- Wellington, NZ
Price Chart
Valuation
- Market Cap
- $188.24M
- P/E
- -32.34
- P/S
- 9.13
- P/B
- 6.03
- EV/EBITDA
- -56.51
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 76.79%
- Op Margin
- -37.06%
- Net Margin
- -27.99%
- ROE
- -17.60%
- ROIC
- -20.44%
Growth & Income
- Revenue
- $32.77M · 35.02%
- Net Income
- $-9,174,389.217 · 39.96%
- EPS
- $-0.04 · 40.13%
- Op Income
- $-10,297,669.194
- FCF YoY
- 53.56%
Performance & Tape
- 52W High
- $0.89
- 52W Low
- $0.41
- 50D MA
- $0.72
- 200D MA
- $0.60
- Beta
- 1.67
- Avg Volume
- 340
Get TickerSpark's AI analysis on VPAHF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our VPAHF Coverage
We haven't published any research on VPAHF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate VPAHF Report →